By Abigail Townsend
Date: Tuesday 08 Apr 2025
(Sharecast News) - Alliance Pharma posted weaker full-year revenues on Tuesday, but insisted it remained well-positioned for medium-term growth.
Form 8.3 - [ALLIANCE PHARMA PLC - 28 04 2025] - ... | 29-Apr-2025 | 12:21 | GlobeNewswire NA |
Form 8.3 - Alliance Pharma PLC 29.04.2025 | 29-Apr-2025 | 11:50 | RNS |
Form 8.3 - Alliance Pharma PLC | 29-Apr-2025 | 10:37 | RNS |
Form 8.5 (EPT/RI) - Alliance Pharma plc | 29-Apr-2025 | 10:09 | RNS |
Form 8.5 (EPT/RI) - Alliance Pharma plc | 29-Apr-2025 | 08:49 | GlobeNewswire NA |
Drug sales lead the way for Boots as revenues ri... | 31-Oct-2008 | The Scotsman |
Look ahead | 13-Sep-2006 | Times |
Look ahead | 12-May-2006 | Times |
Investment Column : Alliance Pharma | 09-Sep-2010 | The Independent |
Investment Column:Alliance Pharma | 19-Mar-2009 | The Independent |
Market report: Thursday latest | 13-Sep-2007 | Daily Mail |
Gloomy summer casts shadow over Next | 10-Sep-2007 | The Independent |
No recent information was found.
Currency | UK Pounds |
Share Price | 64.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 64.60 |
52 Week Low | 29.35 |
Volume | 126,403 |
Shares Issued | 540.57m |
Market Cap | £348.66m |
Beta | 0.01 |
RiskGrade | 119 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 0 |
Neutral | 5 |
Sell | 1 |
Strong Sell | 0 |
Total | 8 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 22-Jun-23 | 22-Dec-22 |
Paid | 18-Jul-23 | 19-Jan-23 |
Amount | 1.18p | 0.59p |
Time | Volume / Share Price |
11:38 | 28,839 @ 64.41p |
11:35 | 2,265 @ 64.50p |
11:35 | 4,378 @ 64.50p |
11:33 | 14,755 @ 64.41p |
11:32 | 5,074 @ 64.50p |
CFO | Andrew Franklin |
Chair | Camillo Pane |
CEO | Nick Sedgwick |
You are here: research